In addition, overexpression of PAFAH1B3 had a worse OS in most clinical and demographic subgroups of LIHC, including pathologic stage, histologic stage, TNM stage, residual tumor, gender, age, adjacent hepatic tissue inflammation, height, and weight (Figures 8A–D and Table 1). The gene discussed is PAFAH1B3; the disease is neoplasm.